A reputable clinic should never move straight from enquiry to cannula. How clinics screen for infusion suitability is one of the clearest signs of whether a service is clinically responsible, because IV therapy is not a retail transaction. It is a healthcare intervention that requires an appropriate assessment of risk, benefit and patient-specific factors.
For patients, that screening process helps answer a simple but important question: is this infusion appropriate for me, today, in this setting? For clinic operators and practitioners, it forms part of safe practice, informed consent and defensible clinical governance. The detail may vary between services, but the principle is constant. Suitability should be established before treatment begins, not during it.
What infusion suitability screening is designed to achieve
Screening is not simply a tick-box exercise or an administrative hurdle. Its purpose is to identify contraindications, clarify the clinical rationale for treatment, assess whether the person can safely receive intravenous therapy, and decide whether modifications or further review are needed.
A good assessment also protects against overpromising. Some people are not suitable for a planned infusion at all. Others may be suitable only after blood tests, dose adjustment, medical sign-off or a different treatment pathway. In some cases, the safest outcome is to decline treatment and advise review by the patient’s GP or another appropriate clinician.
That cautious approach matters particularly for vitamin, nutrient, hydration and NAD+ infusions, where public interest is high but suitability is highly individual. The same infusion can be straightforward for one person and inappropriate for another, depending on their medical history, current symptoms, medicines and underlying conditions.
How clinics screen for infusion suitability in practice
Most responsible clinics start with a detailed pre-treatment assessment. This often begins before the appointment through a health questionnaire, followed by review by a suitably qualified clinician. The questionnaire should go beyond basic demographics. It should ask about current health concerns, diagnosed medical conditions, allergies, previous reactions to medicines or infusions, prescription medicines, over-the-counter products and supplements.
Pregnancy and breastfeeding status, renal issues, liver disease, cardiovascular conditions and neurological history may all be relevant depending on the infusion proposed. So may a history of asthma, atopy or prior anaphylaxis. A clinic also needs to understand why the patient is seeking treatment and whether that aim is realistic within safe practice.
The assessment should not rely entirely on written answers. A clinician should review any red flags, clarify ambiguous responses and explore issues that may alter the risk profile. If a patient reports chest symptoms, unexplained weight loss, acute infection, severe fatigue without diagnosis, or significant new symptoms, the appropriate next step may be medical investigation rather than elective IV therapy.
Medical history and current health status
The medical history is the backbone of screening. This is where clinics identify conditions that may increase the risk of fluid overload, electrolyte imbalance, adverse reactions or poor tolerance of ingredients. Kidney function is a common example. Some vitamins, minerals and fluid volumes may be unsuitable or require particular caution in people with impaired renal function.
Cardiac history also matters. A person with heart failure, uncontrolled hypertension or certain arrhythmias may not be an appropriate candidate for some infusions, especially where fluid volume is significant. Likewise, patients with active infection, fever, unstable chronic disease or recent hospital admission may need medical review before any elective treatment proceeds.
Clinics should also ask about previous IV therapy. A prior infusion does not automatically mean future treatment is safe, but previous tolerance, vein access issues or any delayed adverse effects can inform decision-making.
Medicines, supplements and interactions
Medication review is often underappreciated by patients, yet it is central to safe screening. Anticoagulants may affect cannulation considerations. Diuretics, antihypertensives and medicines affecting renal function may alter the suitability of hydration or electrolyte-containing infusions. Certain supplements can also be relevant, particularly if they duplicate ingredients already being administered.
This is one reason responsible clinics avoid generic assumptions. A person may appear fit and well, but the interaction between medicines, supplements and infusion contents may still require caution. Where there is uncertainty, further prescribing review may be needed before treatment is approved.
Allergies and previous reactions
Any history of allergy should be explored properly rather than recorded superficially. Food allergy does not always translate into infusion risk, but it can signal a broader atopic tendency. Previous reactions to injectable treatments, vitamins, preservatives or dressings may be directly relevant.
Clinics also need to distinguish between a mild, transient side effect and a true hypersensitivity reaction. Feeling flushed during a nutrient infusion is different from developing wheeze, urticaria or facial swelling. That distinction affects whether treatment can proceed and what precautions are necessary.
The role of blood tests and observations
Not every infusion requires the same level of investigation, but screening should match the treatment being offered. In some cases, recent blood tests are advisable or necessary, particularly where the infusion includes ingredients that may be inappropriate at high levels or in the presence of impaired organ function.
If a patient is seeking treatment for fatigue, recurrent headaches or general malaise, a clinic should be careful not to present an infusion as a substitute for diagnosis. Depending on the presentation, blood tests may help determine whether there is a plausible deficiency, whether treatment is justified, or whether the patient should be referred back into mainstream medical assessment.
Baseline observations also matter. Pulse, blood pressure, temperature and general clinical appearance can provide immediate safety information on the day. If someone arrives unwell, dehydrated to a concerning degree, acutely breathless or haemodynamically unstable, an elective infusion appointment is not the place to manage that.
Contraindications are not all absolute
One of the more nuanced aspects of how clinics screen for infusion suitability is that contraindications exist on a spectrum. Some are clear reasons not to proceed. Others are relative concerns that require adjustment, closer monitoring or a different formulation.
For example, a minor intercurrent illness might justify postponement rather than permanent exclusion. Borderline blood pressure may need reassessment after rest. A patient with complex medical history may still be suitable, but only after clinician-led review and a treatment plan tailored to their circumstances.
That is where governance matters. Clinics should have defined inclusion and exclusion criteria, escalation processes and prescribing oversight where relevant. They should also be able to explain why a patient has been accepted, declined or deferred. A vague assurance that treatment is suitable is not enough.
Informed consent is part of suitability screening
Suitability is not only about physiology. It also includes whether the patient understands what the infusion is for, what the evidence supports, what the limitations are, and what risks may arise. Consent is only valid if the person has been given balanced information.
That discussion should cover expected effects, uncertainty where it exists, possible side effects, cannulation risks, and signs of adverse reaction. Patients should also know what aftercare is available and what to do if symptoms develop later. If a patient feels pressured, hurried or poorly informed, the consent process is not adequate.
This is particularly important in wellness-adjacent areas of IV therapy, where expectation can sometimes outpace evidence. Responsible clinics should not use screening as a route to justify treatment already decided upon. The assessment should remain open to the possibility that the correct answer is no.
What good clinics do when someone is not suitable
A safe clinic is defined as much by the treatments it declines as by the ones it provides. If a patient is not suitable, the response should be clear, documented and proportionate. That may mean postponing treatment, requesting blood tests, seeking further medical history, recommending GP review, or advising urgent care if red-flag symptoms are present.
This can be disappointing for patients, but it is a mark of professional standards, not poor service. At IVCentre, that principle sits at the heart of responsible IV practice: patient interest comes before appointment conversion.
For clinic operators, this also reduces legal and clinical risk. Proceeding in the face of unresolved contraindications, incomplete history or unclear indication can create avoidable harm and weaken the integrity of the service.
Signs that screening may be inadequate
Patients and professionals can usually recognise weak screening when they see it. If treatment is approved without meaningful health questions, without clinician review, or without any discussion of medicines, allergies and relevant conditions, standards are unlikely to be strong.
The same applies if every patient appears to receive the same recommendation, if blood tests are never considered where clinically relevant, or if consent is treated as a formality. Convenience has a place in healthcare access, but not at the expense of proper assessment.
A credible clinic should be able to explain its process in plain language. It should be clear who reviews patients, how concerns are escalated, when treatment is deferred, and what emergency procedures are in place if an adverse event occurs.
Careful screening can feel slower than a sales-led model, but it is the safer one. If a clinic takes time to understand your health status before recommending an infusion, that is usually a sign that it is treating IV therapy with the seriousness it requires.